ISSN: 2078-6891

Journal Home

Journal Guideline

Journal of Gastrointestinal Oncology Q3 Unclaimed

Pioneer Bioscience Publishing Company (PBPC) Hong Kong

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Gastrointestinal Oncology is a journal indexed in SJR in Oncology and Gastroenterology with an H index of 51. It has an SJR impact factor of 0,606 and it has a best quartile of Q3. It has an SJR impact factor of 0,606.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Gastroenterology (Q3) Oncology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,606

SJR Impact factor

51

H Index

300

Total Docs (Last Year)

616

Total Docs (3 years)

10083

Total Refs

1383

Total Cites (3 years)

588

Citable Docs (3 years)

1.96

Cites/Doc (2 years)

33.61

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

European Journal of Cancer Care Q3
Cancer Treatment and Research Communications Q3
ecancermedicalscience Q3
Oncology Letters Q3
Current Problems in Cancer Q3

Compare this journals

Aims and Scope

Best articles by citations

Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer

An unusual case of obstructive jaundice: ampullary Burkitt lymphoma

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation

An unusual case of primary acinar cell carcinoma of the liver and its treatment

Preferential use of imaging modalities in staging newly diagnosed rectal cancer: a survey of US radiation oncologists

CT-based assessment of visceral adiposity and outcomes for esophageal adenocarcinoma

Clinical outcomes of endoscopic submucosal tunnel dissection compared with conventional endoscopic submucosal dissection for superficial esophageal cancer: a systematic review and meta-analysis

Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma

Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance

First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age

Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?

Staging and survival of colorectal cancer (CRC) in octogenarians: Nationwide Study of US Veterans

SHOW MORE ARTICLES

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

Epidemiological profile of gastric cancer in the northwestern region of Algeria: about 116 cases

Osteonecrosis of the jaw associated with ziv-aflibercept

Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer

Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets

Trends in surgery and disparities in receipt of surgery for intrahepatic cholangiocarcinoma in the US: 2005-2014

Outcomes of endoscopic submucosal dissection in esophageal adenocarcinoma staged T1bN0 by endoscopic ultrasound in non-surgical patients

Investigation of the changes in the expression levels of MOZ gene in colorectal cancer tissues

Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer - retrospective analysis of response

The platelets-neutrophils to lymphocytes ratio: a new prognostic marker in metastatic colorectal cancer

Quality of life as a fundamental outcome after curative intent gastrectomy for adenocarcinoma: lessons learned from patients

Clinical fate of T0N1 esophageal cancer: results from the National Cancer Database